See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439222_2025_Agios_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001439222, Agios Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 965,600,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,675,000 |
| 3 | remainder_Assets | 685,924,000 |
| 4 | LiabilitiesCurrent | 81,156,000 |
| 5 | LiabilitiesNoncurrent | 41,087,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 3,832,507 |
| 8 | SellingGeneralAndAdministrativeExpense | 193,768,569 |
| 9 | ResearchAndDevelopmentExpense | 306,766,057 |
| 10 | remainder_Expenses | 29,014,602 |
| 11 | remainder_Revenues | 34,144,434 |
| 12 | remainder_NetIncome | 771,526,232 |
| 13 | remainder_ComprehensiveNetIncome | 6,728,459 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,663,199,000 |
| 1 | Liabilities | 122,243,000 |
| 2 | Expenses | 533,381,735 |
| 3 | Revenues | 34,144,434 |
| 4 | StockholdersEquity | 1,540,956,000 |
| 5 | NetIncome | 272,288,931 |
| 6 | ComprehensiveNetIncome | 275,653,160 |
| 7 | BaseVar | 1,565,611,430 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.07 |
| 9 | EconomicCapitalRatio | 4.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
